Skip to Main Content

Paper Details

Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities.
Nat Cancer
146
2021
GBM, Mitochondrial GBM, SLC45A1, amino acid, cancer, glioblastoma, glucose, glucose-proton, glycolytic/plurimetabolic subtype, mitochondrial GBM, mitochondrial glioma, mitochondrial glioma cells, mitochondrial subtype, neuronal, proliferative, proliferative/progenitor, single cells, tumor, tumor cell states
Author NameAffiliation
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Mario L Suv??Broad Institute of Harvard and MIT
Mario L Suv??Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School
Mario L Suv??Broad Institute of Harvard and MIT
Fuchou TangPeking University
Michele CeccarelliUniversity of Naples Federico II
Michele Ceccarelli
Anna LasorellaInstitute for Cancer Genetics, Columbia University Medical Center
Anna LasorellaHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center
Anna LasorellaColumbia University Medical Center
Anna LasorellaColumbia University Medical Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Antonio IavaroneHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneInstitute for Cancer Genetics, Columbia University Medical Center
Antonio IavaroneHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center
Antonio IavaroneColumbia University Medical Center
Antonio IavaroneColumbia University Medical Center
  • 1 - 19

Datasets

Release 1.2